SightfileU.S. market data from official filings
Companies › LNSR
LENSAR INC (LNSR)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001320350 · EDGAR filings · Updated 2026-06-23
LENSAR INC (LNSR) has reported institutional ownership of 42.6%, with 87 institutional managers holding positions valued at $30.7M per the latest 13F reporting period.
Institutional ownership
42.6%
Institutional managers
87
Reported 13F value
$30.7M
Insider activity
14 trans.
$0 net flat
Latest updates
- 2026-06-23 — DEFA14A filed
- 2026-06-23 — ARS filed
- 2026-06-23 — Proxy statement (DEF 14A) filed
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, LENSAR INC has 87 institutional holders and institutional ownership of 42.6%.
Insider activity
Insiders reported 14 transactions (0 buys, 0 sells) across 10 reporting insiders, with a net reported value of $0.
Related companies
COYA THERAPEUTICS INC (COYA) · COMPUGEN LTD (CGEN) · AGENUS INC (AGEN) · CAPSOVISION INC (CV) · ALPHA TAU MEDICAL LTD (DRTS) · EXAGEN INC (XGN)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-23.